These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 14679948

  • 1. Insulin therapy for type 2 diabetes.
    Pergallo-Dittko V.
    Diabetes Self Manag; 2003; 20(5):17, 21, 23-4. PubMed ID: 14679948
    [No Abstract] [Full Text] [Related]

  • 2. Insulin allergy and insulin resistance.
    Lebovitz HE.
    Curr Ther Endocrinol Metab; 1997; 6():500-4. PubMed ID: 9174796
    [No Abstract] [Full Text] [Related]

  • 3. Early use of insulin in type 2 diabetes.
    Eldor R, Stern E, Milicevic Z, Raz I.
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S30-5. PubMed ID: 15955372
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E, Schnell O.
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract] [Full Text] [Related]

  • 6. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients.
    Mayorov AY, Naumenkova IV, Antsiferov MB, Dedov II.
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S54-9. PubMed ID: 15955377
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Intensive insulin therapy].
    Landgraf R, Huber RM, Bachmann A, Lohr R.
    Dtsch Med Wochenschr; 2008 Apr; 133(17):901-12. PubMed ID: 18415916
    [No Abstract] [Full Text] [Related]

  • 9. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.
    Crasto W, Jarvis J, Hackett E, Nayyar V, McNally PG, Davies MJ, Lawrence IG.
    Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173
    [Abstract] [Full Text] [Related]

  • 10. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ, Weiland F.
    Pharm Unserer Zeit; 2002 Apr; 31(3):280-92. PubMed ID: 12071125
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M, Orsini-Federici M.
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Initiating insulin in type 2 diabetes.
    Ravina A.
    Isr Med Assoc J; 2004 Dec; 6(12):787. PubMed ID: 15609901
    [No Abstract] [Full Text] [Related]

  • 15. Treatment options for type 2 diabetes. Finding what's best for you.
    Clark W.
    Diabetes Self Manag; 2002 Dec; 19(3):6-10, 13. PubMed ID: 12091971
    [No Abstract] [Full Text] [Related]

  • 16. Assessing the controversies of insulin therapy in patients with type 2 diabetes mellitus.
    Kuritzky L, Nelson SE.
    J Fam Pract; 2005 Jun; 54(6):S3-6. PubMed ID: 16021782
    [No Abstract] [Full Text] [Related]

  • 17. Achieve better glucose control for your hospitalized patients.
    Woolever DR.
    J Fam Pract; 2008 Dec; 57(12):782-8. PubMed ID: 19080760
    [No Abstract] [Full Text] [Related]

  • 18. [Lantus is superior in BOT (basic oral therapy) to standard mixed insulin].
    Krankenpfl J; 2004 Dec; 42(5-6):172. PubMed ID: 15527234
    [No Abstract] [Full Text] [Related]

  • 19. Non-insulin-dependent diabetes mellitus.
    Edelman SV, Henry RR.
    Curr Ther Endocrinol Metab; 1997 Dec; 6():430-8. PubMed ID: 9174785
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.